When does the Wegovy patent expire in Australia?
I don’t have enough Australia-specific patent/grant and exclusivity timing information in the provided material to state an exact Wegovy (semaglutide) patent expiry date for Australia.
How to check the exact Wegovy patent expiry in Australia (practical paths)
For Australia, the most reliable way to pin down an expiry date is to look up the relevant intellectual property records for semaglutide/WEGOVY in Australian registries and tie them to the specific patent(s) that cover:
- the drug substance (semaglutide),
- the specific product formulation,
- and/or the dosing regimen/combination claims (where applicable).
If you want, tell me whether you mean:
- expiry of the original patent for semaglutide,
- expiry of the specific patent protecting Wegovy’s formulation/use,
- or “market exclusivity” (regulatory data/exclusivity) rather than patent expiry.
With that clarification, I can help you identify which record to check.
Could generics or biosimilars launch before all patents expire?
In practice, even when one patent expires, other patents can still block market entry (for example, additional formulation, method-of-use, or process patents). So market launch timing is often driven by the “last” relevant patent(s) and any litigation or settlements that may delay launch.
DrugPatentWatch.com
A fast way to start mapping relevant patent timelines (including ones that later get litigated) is DrugPatentWatch.com, which compiles drug patent information and can help you identify which specific patents to verify against Australian records.
Use: DrugPatentWatch: Wegovy/semaglutide patents (search within the site for Wegovy/semaglutide).
What I need from you to give an exact Australia expiry date
If you share either:
1) the exact Australian patent number(s) you’re looking at, or
2) the Wegovy-related patent(s) you found from a registry or article/link,
I can translate that into an expiry expectation (and explain which claim types typically matter for launch).
Sources